The antithyroid drugs market consists of sales of antithyroid drugs and related services which are used for the treatment of hyperthyroidism. Hyperthyroidism is caused by over production of thyroid hormones in children, adults and pregnant women. Anti-thyroid class of drugs are also called thionamides which block the formation of thyroid hormone from over active thyroid gland.
The global antithyroid drugs market was valued at about $2.46 billion in 2018 and is expected to grow to $2.79 billion at a CAGR of 3.2% through 2022.
